Molecular remission of CML after autotransplantation followed by adoptive transfer of costimulated autologous T cells.
about
Adoptive T cell therapy: Addressing challenges in cancer immunotherapyToward synthetic biology with engineered T cells: a long journey just begun.Efficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5T-cell reconstitution and expansion after hematopoietic stem cell transplantation: 'T' it up!Immunity for tumors and microbes after autotransplantation: if you build it, they will (not) come.New insights into antigen specific immunotherapy for chronic myeloid leukemiaManufacturing validation of biologically functional T cells targeted to CD19 antigen for autologous adoptive cell therapy.Adoptive immunotherapy: good habits instilled at youth have long-term benefits.Programming tumor-reactive effector memory CD8+ T cells in vitro obviates the requirement for in vivo vaccination.Artificial antigen-presenting cells for use in adoptive immunotherapy.Cellular immunotherapy for plasma cell myeloma.Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies.The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma.Bioengineering of Artificial Antigen Presenting Cells and Lymphoid Organs.A comparison between cytokine- and bead-stimulated polyclonal T cells: the superiority of each and their possible complementary role.Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer.Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma.Enhancement of T cell activation by immobilized hu5C8 (anti-CD40L) monoclonal antibody
P2860
Q24805804-9A1AD4CD-4170-4C3E-8E62-BDA128D2FF80Q34240817-29C0FD11-940A-4678-AC52-8B0A584111C1Q34325074-546960BD-D33D-4EB3-AE18-22F8C6A292CAQ36087036-A9CE6B83-24DA-44C4-8076-5700DA7B3544Q36331221-1BC1FC67-9189-4B40-8FF9-85EA82AE1E3FQ36513477-7D7A7936-8C88-485A-A492-DDB16CDC85DEQ37196769-68670D16-837F-4F8C-AEC4-85ECFCB53149Q37257225-AF9DC60F-D3BD-4F8E-BF7A-C82EA70C71CFQ37334596-D8D8D30C-936A-4238-B5C3-0223A2F75E98Q37778699-BDB23F4C-D0C0-4E89-9519-1C0B1E59ABC3Q38104288-C459DF31-7DCA-49D7-9BC5-1C1FE2AA4FE7Q38753649-115B8BC6-6909-49A9-B606-E1E695C7E945Q39131072-E207A9EF-C816-4857-AACD-3E8BC4181742Q40044791-C1C20E5B-1026-4574-A7CB-2DA7760EB351Q42079725-B6ED3343-002A-46D5-9876-27B624B71CBFQ51987984-18AF67E6-2EFA-4864-8BE3-AF8D79151DFAQ52579654-DF4D9CE0-CF1F-40E7-B6B4-34964E311B06Q56900682-925CA247-D6A7-4BAF-9E64-21780CBA15B2
P2860
Molecular remission of CML after autotransplantation followed by adoptive transfer of costimulated autologous T cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Molecular remission of CML aft ...... stimulated autologous T cells.
@en
Molecular remission of CML aft ...... stimulated autologous T cells.
@nl
type
label
Molecular remission of CML aft ...... stimulated autologous T cells.
@en
Molecular remission of CML aft ...... stimulated autologous T cells.
@nl
prefLabel
Molecular remission of CML aft ...... stimulated autologous T cells.
@en
Molecular remission of CML aft ...... stimulated autologous T cells.
@nl
P2093
P2860
P356
P1476
Molecular remission of CML aft ...... stimulated autologous T cells.
@en
P2093
Meisenberg B
Rapoport AP
Ratterree B
P2860
P2888
P356
10.1038/SJ.BMT.1704317
P407
P577
2004-01-01T00:00:00Z
P5875
P6179
1004709499